Advertisement

Picture [iito] Made Without Love 650x80px
All > Germany >

Deals > Northern Germany

Find below deals from the Northern German Federal States of Bremen (HB), Hamburg (HH), Mecklenburg-Vorpommern (MVP), Niedersachsen (NS) and Schleswig-Holstein (SWH). Listed are deals for this region as well as from organisations located there.

Total search results: 672 | Ordered by Date (descending)
1 2 3 4 5 6 7  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Enzymicals–Syngulon: enzyme production technology, 202005– license non-excl to antibiotic-free selection technology of Syngulon 2020-05-15
OTHER–Enzymicals: enzymes, 202005 service production + supply of diagnostic enzymes using antibiotic-free production for undisclosed world leader 2020-05-15
Centogene–Ubirch: blockchain technology, 202004 collab announcing secure blockchain solution for storing SARS-CoV-2 test results 2020-04-17
Evotec–Leon-Nanodrugs: nanoparticle technology, 202004– collab €na strategic partnership incl equity investment 2020-04-16
Leon-Nanodrugs–Evotec: investment, 202004 financing round Series B incl new + lead investor Evotec 2020-04-16
Centogene–FTI Consulting: public relations, 202004 service existent by FTI Consulting 2020-04-15
Evotec–PanCella: iPSC technology, 202004– license €na for use of iACT Stealth Cells + FailSafe technology with EVOcells platform 2020-04-02
PanCella–Evotec: investment, 202004 minority equity investment €na by Evotec in connection with license agreement 2020-04-02
Koki Holdings–Eppendorf: investment, 202003– acquisition €na of Koki’s Centrifuge + Processing business by Eppendorf from KKR 2020-03-19
Merck (DE)–Dermapharm: investment, 202002–202003 acquisition €na of Merck’s allergy business Allergopharma by Dermapharm Holding SE 2020-02-19
Temedica–Public Performance: public relations, 202002 service existent by Public Performance 2020-02-01
Riemser–Esteve: investment, 202001– acquisition €na of Riemser from Ardian by Esteve 2020-01-08
Aeovian Pharmaceuticals–Evotec: investment, 201912 investment existent Evotec owns 5.83% of voting rights 2019-12-31
Autobahn Labs–Evotec: investment, 201912 investment existent Evotec owns 33.33% of voting rights 2019-12-31
Blacksmith Medicines–Evotec: investment, 201912 investment existent Evotec owns 15.09% of voting rights 2019-12-31
Breakpoint Therapeutics–Evotec: investment, 201912 investment existent Evotec owns 48.6% of voting rights 2019-12-31
Carrick Therapeutics–Evotec: investment, 201912 investment existent Evotec owns 4.29% of voting rights 2019-12-31
Celmatix–Evotec: investment, 201912 investment existent Evotec owns 25.02% of voting rights 2019-12-31
Eternygen–Evotec: investment, 201912 investment existent Evotec owns 24.97% of voting rights 2019-12-31
Exscientia–Evotec: investment, 201912 investment existent Evotec owns 23.21% of voting rights 2019-12-31
Fibrocor Therapeutics–Evotec: investment, 201912 investment existent Evotec owns 16% of voting rights of Fibrocor LLP 2019-12-31
Forge Therapeutics–Evotec: investment, 201912 investment existent Evotec owns 15.09% of voting rights 2019-12-31
FSHD Unlimited Coop–Evotec: investment, 201912 investment existent Evotec owns 21.12% of voting rights 2019-12-31
Immunitas Therapeutics–Evotec: investment, 201912 investment existent Evotec owns 6.44% of voting rights 2019-12-31
Topas Therapeutics–Evotec: investment, 201912 investment existent Evotec owns 28.44% of voting rights 2019-12-31
Provecs–NONE: investment, 201912–202001 bankruptcy AG Hamburg 67g IN 290/19 insolvency + dissolution Provecs Medical GmbH 2019-12-30
Abcalis–Germany (govt): grant, 201912 EXIST research transfer grant for founding from BMWi (plus ESF grant) 2019-12-10
Biological Industries (IL)–Sartorius: investment, 201912 acquisition of just over 50% for €45m in cash with option to acquire further 20% 2019-12-05
Indivumed–Biognosys: MS-based proteomics, 201912– collab integration of HRM MS proteomics data into multi-omics IndivuType cancer database 2019-12-02
Immunitas Therapeutics–Evotec: investment, 201911 financing round Series A totalling $39m incl co-investor Evotec 2019-11-21
Evotec–Merck (DE): CRISPR technology, 201911– license to CRISPR IP portfolio from Merck to Evotec 2019-11-12
Vifor Pharma–Evotec: drug r+d, 201911– collab establishment 50/50 joint venture for nephrology treatments using NURTuRE biobank + PanHunter s/w 2019-11-06
AstraZeneca–BBG/Braun Group: quetiapine fumarate, 201910– acquisition $178m upfront + up to $61m rights to Seroquel/XR in Europe + RU by Cheplapharm 2019-10-30
Danaher–Sartorius: investment, 201910– acquisition $750m three life science businesses by Sartorius part of regulatory clearance for GE/Danaher deal 2019-10-21
Celmatix–Evotec: drug discovery services, 201910– collab €na developm pre-clinical programs for reproductive women’s health 2019-10-09
Dalhousie Univ–Thermo Fisher: mass spectrometer, 201910 supply C$1.3m of Orbitrap Fusion MS system to MS + Proteomics Core Faclity 2019-10-07
Aeovian Pharmaceuticals–Apollo Ventures: investment, 201910 financing round Series A totalling $37m incl founding + co-investor Apollo Health Ventures 2019-10-03
Aeovian Pharmaceuticals–Evotec: investment, 201910 financing round Series A totalling $37m incl founding + co-investor Evotec 2019-10-03
Takeda–Evotec: drug discovery services, 201909– collab strategic multi-year across multiple indications 2019-09-24
LemnaTec–Nynomic: investment, 201908 acquisition €na of assets of LemnaTec Gmbh by Nynomic AG 2019-08-12
Ncardia–Evotec: investment, 201907 acquisition €na of iPSC assets + 17 strong team of bankrupt Ncardia AG in Cologne 2019-07-15
Breakpoint Therapeutics–Evotec: investment, 201907 first financing round totalling €30m incl co-investor Evotec 2019-07-08
Breakpoint Therapeutics–Medicxi Ventures: investment, 201907 first financing round totalling €30m incl lead investor Medicxi 2019-07-08
Breakpoint Therapeutics–Otsuka: investment, 201907 first financing round totalling €30m incl co-investor Taiho Ventures LLC 2019-07-08
Breakpoint Therapeutics–SEVERAL: investment, 201907 first financing round €30m for spin-out from Evotec led by Medicxi + incl Taiho Ventures + Evotec 2019-07-08
Nosopharm–Evotec: antibiotics, 201907– collab €na pre-clinical developm of NOSO-502 + 2nd generation odilorhabdin 2019-07-03
Evotec–SEVERAL: credit, 201906– promissory note €250m with lead arrangers Deutsche Bank + LBBW 2019-06-26
Osteolabs–MVZ Dr Krause: investment, 201906 seed financing round incl investor MVZ Dr Krause und Kollegen Kiel 2019-06-17
Osteolabs–OTHER: investment, 201906 seed financing round incl two business angel investors 2019-06-17
Osteolabs–Schleswig-Holstein (govt): investment, 201906 seed financing round incl investor MGB Kiel Seed und Start-Up Fonds II 2019-06-17
Osteolabs–SEVERAL: investment, 201906 seed financing round from MGB Kiel + MVZ Dr Krause Kiel + two business angels 2019-06-17
Evotec–Leucadia: investor conference, 201906 supply service Evotec AG presents at Jefferies 2019 Global Healthcare Conference NYC 2019-06-06
Evotec–Deutsche Bank: investor conference, 201906 supply service Evotec presents at dbAccess Berlin Conference 2019-06-05
Bruker–908 Devices: sample separation technology, 201906– collab integration of ZipChip microfluidics separation with Bruker TOF systems 2019-06-03
Bruker–Genedata: bioinformatics, 201905– collab product integration Genedata Expressionist supports timsTOF MS systems data 2019-05-31
Bruker–PreOmics: sample preparation technology, 201905– collab developm + marketing PreOmics iST sample preparation on timsTOF Pro MS system 2019-05-31
Helmholtz–Bruker: mass spectrometry software, 201905 supply existent HIPS long-time user of SCiLS Lab + MetaboScape s/w 2019-05-31
Medical Univ South Carolina–Bruker: mass spectrometer, 201905 supply existent timsTOF fleX system early customer Proteomics Center at Med Univ SC 2019-05-31
PHW-Gruppe–Ampersand: investment, 201905 acquisition of Vibalogics GmbH by Ampersand Capital Partners 2019-05-29
Evotec–RBC Capital Markets: investor conference, 201905 supply service Evotec presents at RBC Capital Markets Global Healthcare Conference 2019-05-22
Evotec–Berenberg: investor conference, 201905 supply service Evotec presents at Berenberg European Conference USA in Tarrytown 2019-05-21
Just Biotherapeutics (US)–Evotec: investment, 201905–201907 acquisition 100% for $60m upfront + $30m upfront 2019-05-20
Cutech (IT)–Symrise: investment, 201905 acquisition of Cutech Srl by Symrise 2019-05-06
miRdetect–Bremen (govt): investment, 201905 seed financing round 7-digit € from HTGF + BBM Bremen + a private investor 2019-05-02
miRdetect–High-Tech Gründerfonds: investment, 201905 seed financing round 7-digit € from HTGF + BBM Bremen + a private investor 2019-05-02
miRdetect–OTHER: investment, 201905 seed financing round 7-digit € from HTGF + BBM Bremen + a private investor 2019-05-02
miRdetect–SEVERAL: investment, 201905 seed financing round 7-digit € from HTGF + BBM Bremen + a private investor 2019-05-02
Bruker–Univ Nijmegen: mass spectrometry, 201904– collab establishment of joint Center of Excellence for Translational Omics at RUMC TML 2019-04-16
Univ Nijmegen–Bruker: mass spectrometer, 201904 supply existent several Bruker MS systems at RUMC TML 2019-04-16
Univ Nijmegen–Bruker: mass spectrometer, 201904c supply acquisition of timsTOF Pro IM-MS system by RUMC TML 2019-04-16
Evotec–Indivumed: cancer drug discovery, 201904– collab strategic precision medicine for new colorectal cancer drugs 2019-04-11
Evotec–Mark Foundation: investment, 201903–202102 research funding for two years €na by Mark Foundation with potential financial returns 2019-03-26
Novasep–Sartorius: chromatography, 201903– collab developm of systems for membrane chromatography SSB 2019-03-05
abcr GmbH–Enzymicals: enzymes, 201903– collab distribution expansion ww sale of all catalogue products of Enzymcials by acbr 2019-03-04
BioKryo–Air Liquide: investment, 201903c acquisition of BioKryo by Air Liquide 2019-03-01
Sarepta–Centogene: molecular diagnostics, 201902–202002 collab service identifying DMD patients in MENA region by Centogene 2019-02-28
Samsara Therapeutics–Apollo Ventures: investment, 201902 seed financing round totalling €1m incl lead investor Apollo Ventures 2019-02-26
Samsara Therapeutics–Evotec: medicinal chemistry, 201902 supply service existent compound optimisationn by Evotec 2019-02-26
Samsara Therapeutics–SEVERAL: investment, 201902 seed financing round €1m led by Apollo Ventures 2019-02-26
Evotec–Helmholtz: antibiotics, 201902– collab development with initial focus on cystobactamids with Helmholtz HZI Braunschweig 2019-02-20
Andrew Alliance–Sartorius: electronic pipettes, 201902 collab co-developm + launch Pipette+ system combining Picus hardware with OneLab s/w 2019-02-08
Symrise–SEVERAL: investment, 201902 capital increase €400m with 5.614m new shares at €71.25/share to fund acquisition of ADF/IDF 2019-02-08
Galapagos–Evotec: antifibrotic, 201902– collab + ww commercial rights for Galapagos to small-molecule programme for fibrotic diseases 2019-02-07
ADF/IDF–Symrise: investment, 201901– acquisition $900m by Symrise ANNOUNCED 2019-01-31
Medizinsches Labor Hannover–Labor Limbach: investment, 201901 acquisition 100% of MLH by Limbach Gruppe SE PENDING 2019-01-26
Cell Signaling Technology–Omni Life Science: cell research instruments, 201901– distribution of OLS’ CERO + CESY instruments by Bioké in Benelux 2019-01-14
Evotec–JPMorgan Chase: investor conference, 201901 supply service Evotec presents at JP Morgan Healthcare Conference 2019 2019-01-10
Exscientia–Evotec: investment, 201901 financing round Series B totalling $26m incl $6m from existing investor Evotec AG 2019-01-07
Chiesi–Centogene: genetic services, 201812– collab epidemiology study in lysosomal storage diseases with focus on AM by Centogene for Chiesi GmbH 2018-12-10
Leo Pharma–Evotec: drug discovery services, 201812– collab €na integrated drug discovery to generate leads against innovative dermatic targets 2018-12-04
Evotec–Immuneering: drug discovery software, 201811– collab AI-driven small-molecule drug discovery for hereditary metabolic diseases 2018-11-21
Q-Bioanalytic–Eurofins: investment, 201811 acquisition by Eurofins 2018-11-01
Sanofi–Evotec: drug discovery, 201810– collab partnership BRIDGE LAB031 for early-stage projects out of academic research 2018-10-04
Evotec–Cantor Fitzgerald: investor conference, 201809 supply service Evotec presents at Cantor Fitzegerald Global Healthcare Conference in NY 2018-10-01
Evotec–Berenberg: investor conference, 201809 supply service Evotec attends 7th German Corporate Conference in Munich 2018-09-26
Evotec–Baader Bank: investor conference, 201809 supply service Evotec attends Baader Investment Conference 2018 in Munich 2018-09-24
Almirall–Evotec: drug discovery services, 201809– collab r+d therapies for dermatological diseases 2018-09-17
Evotec–Morgan Stanley: investor conference, 201809 supply service Evotec presents at Morgan Stanley Global Healthcare Conference NY 2018-09-13
Evotec–JPMorgan Chase: investor conference, 201809 supply service Evotec at JP Morgan Cazenove Pan-European Small/Mid Cap Conference London 2018-09-12
Evotec–Goldman Sachs: investor conference, 201809 supply service Evotec at 8th Annual Biotech Symposium in London 2018-09-07
1 2 3 4 5 6 7  next pagenext page



Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 650x65px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture ConsulTech GmbH Berlin Grant Application and Coordination 650x80px

» top